Markets Moderna’s $44 Billion Surge Exposes the True Cost of Its Merck Partnership September 26, 2026 On August 19, 2026, Moderna experienced a seismic shift in valuation. The biotech giant added roughly $44 billion in market value in a single trading session. The catalyst was striking…
Markets Moderna Rockets 93% and Merck Jumps 7% as Melanoma Therapy Meets Phase 3 Goal August 19, 2026 Moderna and Merck Deliver Historic Breakthrough in Cancer Treatment Shares of Moderna rocketed 93% to $121.76 in early Wednesday trading after the biotech company and partner Merck announced that their…